A detailed history of Octavia Wealth Advisors, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Octavia Wealth Advisors, LLC holds 2,521 shares of ABBV stock, worth $418,385. This represents 0.07% of its overall portfolio holdings.

Number of Shares
2,521
Previous 3,060 17.61%
Holding current value
$418,385
Previous $474,000 3.16%
% of portfolio
0.07%
Previous 0.08%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 15, 2024

SELL
$159.82 - $182.1 $86,142 - $98,151
-539 Reduced 17.61%
2,521 $459,000
Q4 2023

Jan 30, 2024

BUY
$137.6 - $154.97 $104,300 - $117,467
758 Added 32.93%
3,060 $474,000
Q3 2023

Oct 30, 2023

BUY
$133.59 - $154.65 $21,240 - $24,589
159 Added 7.42%
2,302 $343,000
Q2 2023

Jul 18, 2023

BUY
$132.51 - $164.9 $26,767 - $33,309
202 Added 10.41%
2,143 $288,000
Q1 2023

Apr 20, 2023

BUY
$144.61 - $166.54 $4,627 - $5,329
32 Added 1.68%
1,941 $309,000
Q4 2022

Jan 19, 2023

BUY
$138.31 - $165.87 $7,330 - $8,791
53 Added 2.86%
1,909 $0
Q3 2022

Oct 17, 2022

SELL
$134.21 - $153.93 $18,118 - $20,780
-135 Reduced 6.78%
1,856 $249,000
Q2 2022

Jul 18, 2022

SELL
$137.62 - $174.96 $137,207 - $174,435
-997 Reduced 33.37%
1,991 $305,000
Q1 2022

Apr 20, 2022

SELL
$131.98 - $163.75 $4,883 - $6,058
-37 Reduced 1.22%
2,988 $484,000
Q4 2021

Jan 28, 2022

SELL
$107.43 - $135.93 $19,015 - $24,059
-177 Reduced 5.53%
3,025 $410,000
Q3 2021

Nov 12, 2021

BUY
$106.4 - $120.78 $60,860 - $69,086
572 Added 21.75%
3,202 $345,000
Q2 2021

Jul 26, 2021

BUY
$105.21 - $117.21 $28,091 - $31,295
267 Added 11.3%
2,630 $296,000
Q1 2021

May 10, 2021

BUY
$102.3 - $112.62 $241,734 - $266,121
2,363 New
2,363 $256,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $293B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Octavia Wealth Advisors, LLC Portfolio

Follow Octavia Wealth Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Octavia Wealth Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Octavia Wealth Advisors, LLC with notifications on news.